Patents-Review.com
🔗 Permalink
Assignee profile:

ABBVIE BIOTECHNOLOGY LTD.

City:

Hamilton

Country:

Bermuda

Published Applications:

100

Last publication date:

2021-04-29

Patent Grants:

89

Last grant date:

2021-11-09

Top Inventors for applications by ABBVIE BIOTECHNOLOGY LTD.

These are the the leading inventors for applications assigned to ABBVIE BIOTECHNOLOGY LTD.:

Recent patent applications by ABBVIE BIOTECHNOLOGY LTD.

ABBVIE BIOTECHNOLOGY LTD. based in Hamilton, BM has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-04-29 ✅ Patent 11,167,030 granted on 2021-11-09
US20210121567A1
Human necessities

Protein formulations and methods of making same

 #2 | 2021-04-22 ✅ Patent 11,191,834 granted on 2021-12-07
US20210113695A1
Human necessities

Protein formulations and methods of making same

 #3 | 2019-10-03 ✅ Patent 11,083,792 granted on 2021-08-10
US20190298829A1
Human necessities

Purified antibody composition

 #4 | 2018-05-31 ✅ Patent 11,565,048 granted on 2023-01-31
US20180147358A1
Human necessities

Automatic injection devices having overmolded gripping surfaces

 #5 | 2018-02-08 ✅ Patent 9,913,902 granted on 2018-03-13
US20180036407A1
Human necessities

Purified antibody composition

 #6 | 2017-06-08 ✅ Patent 9,738,714 granted on 2017-08-22
US20170158759A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #7 | 2017-06-01 ✅ Patent 9,750,808 granted on 2017-09-05
US20170151329A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #8 | 2017-05-25 ✅ Patent 9,732,152 granted on 2017-08-15
US20170145087A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #9 | 2017-03-02 ✅ Patent 9,950,066 granted on 2018-04-24
US20170056498A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #10 | 2016-09-29 ✅ Patent 9,546,212 granted on 2017-01-17
US20160280777A1
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #11 | 2016-09-22 ✅ Patent 9,512,216 granted on 2016-12-06
US20160272704A1
Chemistry; metallurgy

Use of TNFα inhibitor

 #12 | 2016-08-04 ✅ Patent 10,022,503 granted on 2018-07-17
US20160220765A1
Human necessities

Removal of needle shield from syringes and automatic injection devices

 #13 | 2016-06-30 ✅ Patent 9,499,615 granted on 2016-11-22
US20160185849A1
Chemistry; metallurgy

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

 #14 | 2016-06-09 ✅ Patent 9,878,102 granted on 2018-01-30
US20160158450A1
Human necessities

Automatic injection devices having overmolded gripping surfaces

 #15 | 2016-06-02 ✅ Patent 9,669,093 granted on 2017-06-06
US20160151488A1
Human necessities

Methods for treating juvenile idiopathic arthritis

 #16 | 2016-03-31 ✅ Patent 9,486,584 granted on 2016-11-08
US20160089495A1
Human necessities

Automatic injection device

 #17 | 2016-03-24 ✅ Patent 9,821,117 granted on 2017-11-21
US20160082189A1
Human necessities

Wearable automatic injection device for controlled delivery of therapeutic agents

 #18 | 2016-03-03 ✅ Patent 9,284,370 granted on 2016-03-15
US20160060336A1
Chemistry; metallurgy

Methods for treating juvenile idiopathic arthritis

 #19 | 2016-02-04 ✅ Patent 9,302,011 granted on 2016-04-05
US20160030578A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #20 | 2015-12-17 ✅ Patent 9,328,165 granted on 2016-05-03
US20150361168A1
Chemistry; metallurgy

Purified antibody composition

 #21 | 2015-12-03 ✅ Patent 9,272,042 granted on 2016-03-01
US20150344563A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #22 | 2015-12-03 ✅ Patent 9,295,725 granted on 2016-03-29
US20150344562A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #23 | 2015-12-03 ✅ Patent 9,272,041 granted on 2016-03-01
US20150344561A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #24 | 2015-12-03 ✅ Patent 9,327,032 granted on 2016-05-03
US20150344560A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #25 | 2015-12-03 ✅ Patent 9,289,497 granted on 2016-03-22
US20150343065A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #26 | 2015-10-29 ✅ Patent 9,273,132 granted on 2016-03-01
US20150307605A1
Chemistry; metallurgy

Purified antibody composition

 #27 | 2015-10-29 ✅ Patent 9,220,781 granted on 2015-12-29
US20150306224A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #28 | 2015-08-06 ✅ Patent 9,085,620 granted on 2015-07-21
US20150218269A1
Chemistry; metallurgy

Use of TNFα inhibitor for treatment of psoriatic arthritis

 #29 | 2015-08-06 ✅ Patent 9,090,689 granted on 2015-07-28
US20150218268A1
Chemistry; metallurgy

Use of TNFα inhibitor for treatment of psoriasis

 #30 | 2015-07-16 ✅ Patent 9,764,090 granted on 2017-09-19
US20150196712A1
Human necessities

Relating to automatic injection devices

 #31 | 2015-06-25 ✅ Patent 9,187,559 granted on 2015-11-17
US20150175690A1
Chemistry; metallurgy

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

 #32 | 2015-06-18 ✅ Patent 9,321,846 granted on 2016-04-26
US20150166678A1
Chemistry; metallurgy

Compositions and methods comprising binding proteins for adalimumab

 #33 | 2015-05-28 ✅ Patent 9,334,320 granted on 2016-05-10
US20150147335A1
Chemistry; metallurgy

Methods of treating moderate to severe hidradenitis suppurativa with anti-TNFalpha antibody

 #34 | 2015-04-02 ✅ Patent 9,114,166 granted on 2015-08-25
US20150093394A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #35 | 2015-03-26 ✅ Patent 9,067,992 granted on 2015-06-30
US20150086569A1
Chemistry; metallurgy

Use of TNFα inhibitor for treatment of psoriatic arthritis

 #36 | 2015-03-19 ✅ Patent 9,096,666 granted on 2015-08-04
US20150079103A1
Chemistry; metallurgy

Purified antibody composition

 #37 | 2015-03-19 ✅ Patent 9,102,723 granted on 2015-08-11
US20150079102A1
Chemistry; metallurgy

Purified antibody composition

 #38 | 2015-03-12 ✅ Patent 9,017,680 granted on 2015-04-28
US20150071939A1
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #39 | 2015-03-12 ✅ Patent 8,986,693 granted on 2015-03-24
US20150071938A1
Chemistry; metallurgy

Use of TNFα inhibitor for treatment of psoriasis

 #40 | 2015-02-05
US20150037772A1
Physics

AUTOMATIC INJECTION DEVICE

 #41 | 2015-01-22 ✅ Patent 8,992,926 granted on 2015-03-31
US20150023982A1
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #42 | 2015-01-22 ✅ Patent 9,085,619 granted on 2015-07-21
US20150023977A1
Chemistry; metallurgy

Anti-TNF antibody formulations

 #43 | 2015-01-15 ✅ Patent 9,073,987 granted on 2015-07-07
US20150017175A1
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #44 | 2015-01-08 ✅ Patent 9,561,328 granted on 2017-02-07
US20150011948A1
Human necessities

Automatic injection device

 #45 | 2014-11-20 ✅ Patent 8,916,158 granted on 2014-12-23
US20140341925A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #46 | 2014-11-20 ✅ Patent 8,916,157 granted on 2014-12-23
US20140341924A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #47 | 2014-11-18 ✅ Patent 8,889,135 granted on 2014-11-18
US10163657
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #48 | 2014-11-06 ✅ Patent 8,926,975 granted on 2015-01-06
US20140328855A1
Chemistry; metallurgy

Method of treating ankylosing spondylitis

 #49 | 2014-10-30 ✅ Patent 8,974,790 granted on 2015-03-10
US20140322232A1
Chemistry; metallurgy

Methods of administering anti-TNFα antibodies

 #50 | 2014-10-30 ✅ Patent 8,911,741 granted on 2014-12-16
US20140322228A1
Chemistry; metallurgy

Formulation of human antibodies for treating TNF-alpha associated disorders

 #51 | 2014-10-23 ✅ Patent 8,940,305 granted on 2015-01-27
US20140314781A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #52 | 2014-10-02
US20140296493A1
Chemistry; metallurgy

METHOD OF TREATING DEPRESSION USING A TNFa ANTIBODY

 #53 | 2014-09-30 ✅ Patent 8,846,046 granted on 2014-09-30
US10693233
Chemistry; metallurgy

Low dose methods for treating disorders in which TNFα activity is detrimental

 #54 | 2014-09-25 ✅ Patent 9,339,610 granted on 2016-05-17
US20140288503A1
Human necessities

Removal of needle shield from syringes and automatic injection devices

 #55 | 2014-09-25
US20140286939A1
Chemistry; metallurgy

TREATMENT OF TNFALPHA RELATED DISORDERS

 #56 | 2014-09-25 ✅ Patent 8,906,373 granted on 2014-12-09
US20140286867A1
Chemistry; metallurgy

Use of TNF-alpha inhibitor for treatment of psoriasis

 #57 | 2014-09-18 ✅ Patent 9,017,287 granted on 2015-04-28
US20140276444A1
Human necessities

Automatic injection devices

 #58 | 2014-09-18 ✅ Patent 8,911,737 granted on 2014-12-16
US20140271637A1
Human necessities

Methods of administering anti-TNFα antibodies

 #59 | 2014-09-11 ✅ Patent 8,961,973 granted on 2015-02-24
US20140255396A1
Chemistry; metallurgy

Multiple-variable dose regimen for treating TNFα-related disorders

 #60 | 2014-09-04 ✅ Patent 8,961,974 granted on 2015-02-24
US20140248277A1
Chemistry; metallurgy

Multiple-variable dose regimen for treating TNFα-related disorders

 #61 | 2014-09-04
US20140248276A1
Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

 #62 | 2014-09-04
US20140248275A1
Human necessities

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

 #63 | 2014-08-21 ✅ Patent 8,808,700 granted on 2014-08-19
US20140234222A1
Chemistry; metallurgy

Use of TNF alpha inhibitor for treatment of erosive polyarthritis

 #64 | 2014-07-31
US20140212430A1
Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

 #65 | 2014-07-17
US20140200332A1
Chemistry; metallurgy

LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNF-ALPHA ACTIVITY IS DETRIMENTAL

 #66 | 2014-07-03
US20140186368A1
Chemistry; metallurgy

METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES

 #67 | 2014-06-26
US20140180705A1
Physics

MANAGING HEALTHCARE SERVICES

 #68 | 2014-05-08 ✅ Patent 8,802,102 granted on 2014-08-12
US20140127222A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #69 | 2014-03-27 ✅ Patent 8,795,670 granted on 2014-08-05
US20140086931A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #70 | 2014-03-27 ✅ Patent 8,802,101 granted on 2014-08-12
US20140086930A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #71 | 2014-03-27 ✅ Patent 8,802,100 granted on 2014-08-12
US20140086929A1
Human necessities

Formulation of human antibodies for treating TNF-alpha associated disorders

 #72 | 2013-12-12
US20130330357A1
Chemistry; metallurgy

METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha

 #73 | 2013-12-12
US20130330356A1
Chemistry; metallurgy

METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha

 #74 | 2013-12-05 ✅ Patent 8,906,372 granted on 2014-12-09
US20130323261A1
Human necessities

Purified antibody composition

 #75 | 2013-11-21 ✅ Patent 8,772,458 granted on 2014-07-08
US20130309309A1
Human necessities

Crystalline anti-hTNFalpha antibodies

 #76 | 2013-11-21 ✅ Patent 8,895,009 granted on 2014-11-25
US20130309242A1
Human necessities

Purified antibody composition

 #77 | 2013-10-24 ✅ Patent 8,883,156 granted on 2014-11-11
US20130280267A1
Human necessities

Purified antibody composition

 #78 | 2013-10-17 ✅ Patent 8,916,153 granted on 2014-12-23
US20130273059A1
Chemistry; metallurgy

Purified antibody composition

 #79 | 2013-05-16 ✅ Patent 9,061,005 granted on 2015-06-23
US20130122011A1
Human necessities

Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease

 #80 | 2012-11-15 ✅ Patent 9,265,887 granted on 2016-02-23
US20120289905A1
Human necessities

Automatic injection devices having overmolded gripping surfaces

 #81 | 2012-11-08 ✅ Patent 8,932,591 granted on 2015-01-13
US20120282270A1
Human necessities

Formulation of human antibodies for treating TNF-α associated disorders

 #82 | 2012-10-18 ✅ Patent 8,821,865 granted on 2014-09-02
US20120263731A1
Chemistry; metallurgy

High concentration anti-TNFα antibody liquid formulations

 #83 | 2012-10-11 ✅ Patent 8,753,633 granted on 2014-06-17
US20120258114A1
Chemistry; metallurgy

Human antibodies that bind human TNFα

 #84 | 2012-10-04 ✅ Patent 8,436,149 granted on 2013-05-07
US20120251550A1
Chemistry; metallurgy

Crystalline anti-hTNFalpha antibodies

 #85 | 2012-09-20 ✅ Patent 8,708,968 granted on 2014-04-29
US20120238961A1
Human necessities

Removal of needle shields from syringes and automatic injection devices

 #86 | 2012-08-02 ✅ Patent 8,668,670 granted on 2014-03-11
US20120197209A1
Human necessities

Automatic injection devices

 #87 | 2012-05-24 ✅ Patent 9,086,418 granted on 2015-07-21
US20120129185A1
Physics

Methods and compositions for diagnosing ankylosing spondylitis using biomarkers

 #88 | 2012-05-03 ✅ Patent 9,572,938 granted on 2017-02-21
US20120107783A1
Human necessities

Automatic injection device

 #89 | 2012-01-26 ✅ Patent 9,180,244 granted on 2015-11-10
US20120022499A1
Human necessities

Wearable automatic injection device for controlled delivery of therapeutic agents

 #90 | 2011-12-08 ✅ Patent 8,747,854 granted on 2014-06-10
US20110300151A1
Chemistry; metallurgy

Methods of treating moderate to severe hidradenitis suppurativa with anti-TNF-alpha antibodies

 #91 | 2011-07-21 ✅ Patent 8,758,301 granted on 2014-06-24
US20110178500A1
Human necessities

Firing button for automatic injection device

 #92 | 2011-07-14 ✅ Patent 9,605,064 granted on 2017-03-28
US20110171227A1
Chemistry; metallurgy

Methods and compositions for treatment of skin disorders

 #93 | 2011-03-03 ✅ Patent 8,636,704 granted on 2014-01-28
US20110054414A1
Human necessities

Automatic injection device

 #94 | 2010-06-24 ✅ Patent 8,679,061 granted on 2014-03-25
US20100160894A1
Human necessities

Automatic injection device

 #95 | 2009-10-15 ✅ Patent 8,999,337 granted on 2015-04-07
US20090258018A1
Human necessities

Methods for treating juvenile idiopathic arthritis by inhibition of TNFα

 #96 | 2009-03-12 ✅ Patent 8,969,024 granted on 2015-03-03
US20090068172A1
Chemistry; metallurgy

Compositions and methods comprising binding proteins for adalimumab

 #97 | 2009-01-29 ✅ Patent 9,624,295 granted on 2017-04-18
US20090028794A1
Chemistry; metallurgy

Uses and compositions for treatment of psoriatic arthritis

 #98 | 2008-07-10 ✅ Patent 9,399,061 granted on 2016-07-26
US20080166348A1
Human necessities

Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis

 #99 | 2007-03-29 ✅ Patent 8,715,664 granted on 2014-05-06
US20070071747A1
Chemistry; metallurgy

Use of human TNFα antibodies for treatment of erosive polyarthritis

 #100 | 2006-01-12 ✅ Patent 8,889,136 granted on 2014-11-18
US20060009385A1
Chemistry; metallurgy

Multiple-variable dose regimen for treating TNFα-related disorders

Also check out AbbVie Biotechnology Ltd's (Hamilton, Bermuda) applicant profile with 66 patent applications submitted.

AssigneeID:

46070 ⎘